Charles Schwab Investment Management Inc Arcutis Biotherapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 750,724 shares of ARQT stock, worth $6.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
750,724
Previous 571,318 31.4%
Holding current value
$6.98 Million
Previous $1.85 Million 303.2%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$3.25 - $11.77 $583,069 - $2.11 Million
179,406 Added 31.4%
750,724 $7.44 Million
Q4 2023

Feb 06, 2024
BUY
$1.84 - $4.82 $345,009 - $903,774
187,505 Added 48.85%
571,318 $1.85 Million
Q3 2023

Nov 08, 2023
BUY
$5.31 - $10.98 $286,055 - $591,503
53,871 Added 16.33%
383,813 $2.04 Million
Q2 2023

Aug 09, 2023
BUY
$7.51 - $15.0 $206,074 - $411,600
27,440 Added 9.07%
329,942 $3.14 Million
Q1 2023

May 11, 2023
BUY
$10.23 - $17.14 $7,918 - $13,266
774 Added 0.26%
302,502 $3.33 Million
Q4 2022

Feb 13, 2023
BUY
$13.96 - $20.4 $148,464 - $216,953
10,635 Added 3.65%
301,728 $4.47 Million
Q3 2022

Nov 14, 2022
BUY
$17.85 - $26.95 $1.32 Million - $1.99 Million
73,833 Added 33.98%
291,093 $5.56 Million
Q2 2022

Aug 15, 2022
BUY
$16.33 - $22.2 $266,113 - $361,771
16,296 Added 8.11%
217,260 $4.63 Million
Q1 2022

May 13, 2022
BUY
$14.38 - $22.79 $36,108 - $57,225
2,511 Added 1.27%
200,964 $3.87 Million
Q4 2021

Feb 11, 2022
BUY
$14.98 - $25.5 $39,187 - $66,708
2,616 Added 1.34%
198,453 $4.12 Million
Q3 2021

Nov 16, 2021
BUY
$19.28 - $27.1 $47,332 - $66,530
2,455 Added 1.27%
195,837 $4.68 Million
Q2 2021

Aug 16, 2021
BUY
$24.42 - $34.75 $334,602 - $476,144
13,702 Added 7.63%
193,382 $5.28 Million
Q1 2021

May 17, 2021
BUY
$24.47 - $36.98 $935,757 - $1.41 Million
38,241 Added 27.04%
179,680 $5.2 Million
Q4 2020

Feb 16, 2021
BUY
$17.82 - $31.73 $549,141 - $977,791
30,816 Added 27.86%
141,439 $3.98 Million
Q3 2020

Nov 13, 2020
BUY
$23.44 - $32.28 $993,316 - $1.37 Million
42,377 Added 62.09%
110,623 $3.24 Million
Q2 2020

Aug 14, 2020
BUY
$24.48 - $36.56 $1.13 Million - $1.69 Million
46,225 Added 209.91%
68,246 $2.06 Million
Q1 2020

May 15, 2020
BUY
$18.5 - $36.9 $407,388 - $812,574
22,021 New
22,021 $657,000

Others Institutions Holding ARQT

# of Institutions
172
Shares Held
126M
Call Options Held
498K
Put Options Held
1.64M
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email